Paul J. Chang, M.D., will speak about AI's potential impact on medical imaging during an AIMed breakfast briefing at the University of Chicago School April 9.

Paul J. Chang, M.D., will speak about AI's potential impact on medical imaging during an AIMed breakfast briefing at the University of Chicago School April 9.


Paul J. Chang, M.D., FSIIM, professor and vice-chairman of radiology informatics at the University of Chicago School of Medicine will explain how artificial intelligence (AI) will improve the field of radiology and patient outcomes. This is part of a series of regional AI breakfast briefings hosted by AIMed, a collaborative group that is working to bring various subspecialties together to expand the use of AI to improve medicine.

The event is Tuesday, April 9, 2019, from 8-10 a.m. CDT, at the Gleacher Center, The University of Chicago Booth School of Business Room 300, Lounge 350, located at 450 Cityfront Plaza Dr. in Chicago.

Register for this event:
https://www.eventbrite.co.uk/e/experience-the-future-of-ai-in-radiology-chicago-tickets-56287456297

Creating a collaborative ecosystem and robust infrastructure is important to enable AI to improve the field of radiology and patient outcomes.
Artificial Intelligence has the power to truly transform radiological practice. The benefits of machine learning and deep neural networks in identifying disease earlier and more accurately is irrefutable. The integration of this technology at scale is, however, more challenging. How do we invest in building the necessary frameworks to validate these tools in the clinical setting? How do we ensure we are working in unison as an industry and not in a siloed and duplicative fashion. How do we ensure we maintain physician oversight/domain expertise when these tools are being developed?

Topics to be discussed will include
   · The need for unbiased Ground Truth Data
   · Overhaul of IT infrastructure within the healthcare system at large.
   · Patient privacy/protection issues
   · Develop comprehensive partnerships between clinicians with the vendor community to develop tools of clinical utility and usability
   · How do we speed up research without putting scientific integrity at risk. Is there a hybrid model?
 
Format:
8:00 – 08:30 Arrival, coffee and networking

8:30 – 08:40 Welcome and introduction by Freddy White, CEO AIMed

8:40 – 09:30 Panel discussion 9:30 – 09:50 General Q&A

9:50 – 09:55 Summary and close

9:55 – 10:15 Networking and coffee 

Breakfast pastries, coffee and various refreshmentswill be available.


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now